Ubs Asset Management Americas Inc Molecular Templates, Inc. Transaction History

Ubs Asset Management Americas Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$7.82 - $12.44 $132,330 - $210,509	16,922 Added 151.09%	28,122 $219,000
Q1 2021 May 14, 2021	SELL	$9.33 - $14.05 $103,563 - $155,955	-11,100 Reduced 49.78%	11,200 $141,000
Q4 2020 Mar 01, 2021	BUY	$8.48 - $12.23 $94,976 - $136,976	11,200 Added 100.9%	22,300 $209,000
Q3 2020 Nov 13, 2020	BUY	$9.99 - $14.41 $8,991 - $12,969	900 Added 8.82%	11,100 $121,000
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $125,256 - $179,826	10,200 New	10,200 $140,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.